Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic marker

Cholangiocarcinoma (CCA) is a devastating disease due to resistance to traditional chemotherapies and radiotherapies. New therapeutic strategies against CCA are urgently needed. This study investigated the role of lipocalin-2 (LCN2) in human cholangiocarcinoma as a potential therapeutic target and d...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiang, Kun-Chun, Yeh, Ta-Sen, Wu, Ren-Chin, Pang, Jong-Hwei S., Cheng, Chi-Tung, Wang, Shang-Yu, Juang, Horng-Heng, Yeh, Chun-Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080596/
https://www.ncbi.nlm.nih.gov/pubmed/27782193
http://dx.doi.org/10.1038/srep36138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080596/
https://www.ncbi.nlm.nih.gov/pubmed/27782193
http://dx.doi.org/10.1038/srep36138

Ejemplares similares